يعرض 1 - 10 نتائج من 7,218 نتيجة بحث عن '"ABIRATERONE"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis.

    المؤلفون: Zhu, Qiyu1 (AUTHOR), Chen, Junru1 (AUTHOR), Liu, Haoyang1 (AUTHOR), Zhao, Jinge1 (AUTHOR), Xu, Chenhao1 (AUTHOR), Sun, Guangxi1 (AUTHOR) sungx077@126.com, Zeng, Hao1 (AUTHOR) zengh@scu.edu.cn

    المصدر: BMC Cancer. 6/8/2024, Vol. 24 Issue 1, p1-10. 10p.

    مصطلحات موضوعية: *ABIRATERONE acetate, *BAYESIAN analysis, *HOMOLOGOUS recombination, *POLY(ADP-ribose) polymerase, *GENETIC mutation, *OLAPARIB, *BRAF genes, *GENE targeting

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.

    المؤلفون: Chamorey, Emmanuel1 (AUTHOR) jocelyn.gal@nice.unicancer.fr, Pujalte-Martin, Marc2 (AUTHOR), Ferrero, Jean-Marc2 (AUTHOR), Mahammedi, Hakim3 (AUTHOR), Gravis, Gwenaelle4 (AUTHOR), Roubaud, Guilhem5 (AUTHOR), Beuzeboc, Philippe6 (AUTHOR), Largillier, Remy7 (AUTHOR), Borchiellini, Delphine2,8 (AUTHOR), Linassier, Claude9 (AUTHOR), Bouges, Hélène10 (AUTHOR), Etienne-Grimaldi, Marie-Christine10 (AUTHOR), Schiappa, Renaud1 (AUTHOR), Gal, Jocelyn1 (AUTHOR), Milano, Gérard10 (AUTHOR) gerard.milano@nice.unicancer.fr

    المصدر: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6058. 11p.

    مصطلحات موضوعية: *CASTRATION-resistant prostate cancer, *ABIRATERONE acetate, *PROSTATE cancer patients, *CANCER patients, *OLDER patients, *DOCETAXEL, *ACETATES

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study.

    المؤلفون: Detassis, Simone1,2 (AUTHOR) simone.detassis@optoi.com, Precazzini, Francesca1,3 (AUTHOR), Grasso, Margherita1,4 (AUTHOR), Del Vescovo, Valerio1,5 (AUTHOR), Maines, Francesca6 (AUTHOR), Caffo, Orazio6 (AUTHOR), Campomenosi, Paola7 (AUTHOR), Denti, Michela A.1 (AUTHOR) michela.denti@unitn.it

    المصدر: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5573. 13p.

    مصطلحات موضوعية: *CASTRATION-resistant prostate cancer, *ABIRATERONE acetate, *COMPANION diagnostics, *MICRORNA, *PILOT projects

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.

    المؤلفون: Waseem, Mohammad1 (AUTHOR) mwaseem@umes.edu, Wang, Bi-Dar1,2 (AUTHOR) bwang@umes.edu

    المصدر: Cancers. May2024, Vol. 16 Issue 10, p1933. 20p.

    مصطلحات موضوعية: *ABIRATERONE acetate, *ANTIANDROGENS, *CASTRATION-resistant prostate cancer, *CYTOLOGY, *WOUND healing, *COMBINATION drug therapy, *EPITHELIAL-mesenchymal transition, *RESEARCH funding, *CELLULAR signal transduction, *METASTASIS, *MTOR inhibitors, *ANDROGEN receptors

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework.

    المؤلفون: Jiao, Boshen1,2 (AUTHOR) bjiao@hsph.harvard.edu, Carlson, Josh J.1 (AUTHOR), Garrison, Louis P.1 (AUTHOR), Basu, Anirban1 (AUTHOR)

    المصدر: Value in Health. Apr2024, Vol. 27 Issue 4, p433-440. 8p.

    مصطلحات موضوعية: *ABIRATERONE acetate, *TREATMENT effect heterogeneity, *ANDROGEN deprivation therapy, *COST effectiveness, *DOCETAXEL, *PATIENT preferences, *INSURANCE policies, *ALKALOIDS


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.

    المؤلفون: Yu, Alex1 (AUTHOR) ayu19@its.jnj.com, Hazra, Anasuya1,2 (AUTHOR), Jiao, James Juhui3 (AUTHOR), Hellemans, Peter4 (AUTHOR), Mitselos, Anna4 (AUTHOR), Tian, Hui1 (AUTHOR), Ruixo, Juan Jose Perez5 (AUTHOR), Haddish-Berhane, Nahor1 (AUTHOR), Ouellet, Daniele1 (AUTHOR), Russu, Alberto6 (AUTHOR)

    المصدر: Clinical Pharmacokinetics. Apr2024, Vol. 63 Issue 4, p511-527. 17p.

    مصطلحات موضوعية: *CASTRATION-resistant prostate cancer, *ABIRATERONE acetate, *BACTERICIDAL action, *PATIENT experience, *DATA modeling, *PATIENTS' attitudes


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Cardiovascular Toxicity During androgen Deprivation Therapy with Abiraterone Acetate in Prostate Cancer: A Case Report and Literature Review.

    المؤلفون: Kerboua, E.1 esmakerboua@yahoo.fr, Rekkache, S.2, Raaf, N.3

    المصدر: European Journal of Cardiovascular Medicine. 2024, Vol. 14 Issue 2, p194-197. 4p.

    مصطلحات موضوعية: *PROSTATE cancer, *ABIRATERONE acetate, *CASTRATION-resistant prostate cancer, *ANDROGEN deprivation therapy, *LITERATURE reviews, *CARDIOTOXICITY, *PROSTATE cancer patients

    مصطلحات جغرافية: ALGERIA


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.

    المؤلفون: Nirogi, Ramakrishna1 (AUTHOR) nvsrk@suven.com, Ravula, Jyothsna1 (AUTHOR), Benade, Vijay1 (AUTHOR), Goyal, Vinod Kumar1 (AUTHOR), Pandey, Santosh Kumar1 (AUTHOR), Dogiparti, Dhanunjay1 (AUTHOR), Jayarajan, Pradeep1 (AUTHOR), Kalaikadhiban, Ilayaraja1 (AUTHOR), Jetta, Satish1 (AUTHOR), Palacharla, Veera Raghava Chowdary1 (AUTHOR)

    المصدر: Cancer Chemotherapy & Pharmacology. Mar2024, Vol. 93 Issue 3, p253-264. 12p.

    مصطلحات موضوعية: *ABIRATERONE acetate, *PHARMACOKINETICS, *MALES, *PROSTATE cancer


    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Prostate Cancer and the Mevalonate Pathway.

    المؤلفون: Guerrero-Ochoa, Patricia1 (AUTHOR) pguerrero@iisaragon.es, Rodríguez-Zapater, Sergio2 (AUTHOR) rzapater@unizar.es, Anel, Alberto3 (AUTHOR) anel@unizar.es, Esteban, Luis Mariano4 (AUTHOR) lmeste@unizar.es, Camón-Fernández, Alejandro1 (AUTHOR) acamon@iisaragon.es, Espilez-Ortiz, Raquel1,5,6 (AUTHOR) respilez@salud.aragon.es, Gil-Sanz, María Jesús1,5 (AUTHOR) mjgilsa@salud.aragon.es, Borque-Fernando, Ángel1,4,5,6 (AUTHOR) lmeste@unizar.es

    المصدر: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 4, p2152. 21p.

    مصطلحات موضوعية: *PROSTATE cancer, *ABIRATERONE acetate, *CARCINOGENESIS

    النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer.

    المؤلفون: LAM, Benjamin H. W.1, TSANG, Vivian H. M.1, LEE, M. P.1, Kuen CHAN2, Tsz Chim LIU2, NG, Brian Y. H.3, WO, Barry B. W.4, LEUNG, K. C.4, Wing Ho MUI4, Tim Wai CHAN5, Martin Ho Ching LAM6, SIU, Steven W. K.7, POON, Darren M. C.1,8 mc_poon@clo.cuhk.edu.hk

    المصدر: Clinical Genitourinary Cancer. Feb2024, Vol. 22 Issue 1, pe75-e85.e1. 12p.

    مصطلحات موضوعية: *ABIRATERONE acetate, *DOCETAXEL, *PROSTATE cancer treatment, *PROSTATE-specific antigen, *PROGRESSION-free survival, *OVERALL survival


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث